Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

1(20%)

Results Posted

50%(1 trials)

Terminated

2(40%)

Phase Distribution

Ph phase_1

20%

Ph not_applicable

40%

Ph early_phase_1

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(2)

Detailed Status

Terminated2

Completed2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 21 (20.0%)

N/A2 (40.0%)

Trials by Status

terminated240%

completed240%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

recruitingearly_phase_1

Efficacy of Topical Tyrosine Versus Topical 5-Fluorouracil With Fractional Erbium YAG Laser

NCT07742982

terminatednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT07742982Early Phase 1

Efficacy of Topical Tyrosine Versus Topical 5-Fluorouracil With Fractional Erbium YAG Laser

Recruiting

NCT01219049Not Applicable

L-Tyrosine Supplementation in Patients With Fibromyalgia

Terminated

NCT00000322Phase 2

Tyrosine for Methamphetamine Dependence - 1

Completed

NCT00865514Not Applicable

Pharmacotoxicology of Trichloroethylene Metabolites

Terminated

NCT01676103Phase 1

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5